产品编号 :
Cas No. :
CAS No. |
947669-86-5 |
|---|---|
中文名称 |
WWL113 |
英文名称 |
WWL113 |
别名 |
WWL113 | 4′-[[[Methyl[[3-(4-pyridinyl)phenyl]methyl]amino]carbonyl]oxy]-[1,1′-Biphenyl]-4-carboxylic acid ethyl ester | Ethyl 4′-((methyl(3-(pyridin-4-yl)benzyl)carbamoyl)oxy)-[1,1′-biphenyl]-4-carboxylate | 4'-[[[Methyl[[3-(4-pyridinyl)phenyl]methyl]amin |
标准英文名 |
ethyl 4'-((methyl(3-(pyridin-4-yl)benzyl)carbamoyl)oxy)-[1,1'-biphenyl]-4-carboxylate |
分子式 |
C29H26N2O4 |
分子量 |
466.54 |
精确分子量 |
466.19 |
SMILES |
O=C(C1=CC=C(C2=CC=C(OC(N(C)CC3=CC=CC(C4=CC=NC=C4)=C3)=O)C=C2)C=C1)OCC |
标准SMILES |
CCOC(=O)C1=CC=C(C=C1)C1C=CC(=CC=1)OC(=O)N(C)CC1=CC=CC(=C1)C1=CC=NC=C1 |
用途 |
WWL113 is a selective and orally active inhibitor of Ces3 and Ces1f, with IC50 values of 120 nM and 100 nM, respectively; it exhibits excellent selectivity for 60-kDa serine hydrolases; it significantly increases UCP1 protein expression in brown adipocytes; it partially and significantly inhibits the accumulation of PGE2; it ameliorates obesity-diabetes and improves multiple features of metabolic syndrome in mice, including reducing levels of nonesterified free fatty acids (NEFAs), triglycerides (TGs), total cholesterol, and fasting glucose, as well as enhancing glucose tolerance. |
InChIKey |
AKIIPHDGVCFVCC-UHFFFAOYSA-N |
|
|
评论 |
|---|